Teva Pharmaceutical Industries Ltd (NYSE:TEVA) reported third-quarter 2024 sales of $4.33 billion on Wednesday. It beat the ...

Because of those demand increases, the medications were previously impacted by the nationwide drug shortage. But before ...

Heritage Pharmaceuticals and Apotex will pay $49.1 million in a settlement with Pennsylvania, New Jersey and other states.

Telehealth company Hims & Hers said late Monday in an earnings update that it plans to launch a generic version of Novo ...

As pharmaceutical companies embrace antibody-drug conjugates (ADCs) as a way to treat cancer, drug services providers are ...

National settlements with two generic drug companies over allegedly massive price-fixing conspiracies could be the first of ...

Novo Nordisk shares were up Wednesday following an earnings report that showed continued sales growth of its obesity drug.

The company narrowed its full-year guidance as its blockbuster weight-loss drug soars in popularity.

Streamlining processes like trial site selection and FDA documentation can make a meaningful difference in development timelines.

The drugmaker hopes to show CagriSema leads to at least 25% weight loss, without increased side effects. Its lead in a ...

Analyst Gil Blum from Needham maintained a Buy rating on Recursion Pharmaceuticals (RXRX – Research Report) and keeping the price target ...

Some people who took a new schizophrenia drug for one year improved with only a few side effects, but many dropped out of the ...